Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Effect of dose escalation with single opioid, fentanyl matrix in patients not controlling cancer pain: a multicenter, prospective, observational study in Korea.

Koh SA, Lee KH, Kim MJ, Lee KT, Park SW, Nam SH, Ryoo HM.

Cancer Res Treat. 2013 Dec;45(4):263-9. doi: 10.4143/crt.2013.45.4.263. Epub 2013 Dec 31.

2.

Fentanyl buccal tablet.

Messina J, Darwish M, Fine PG.

Drugs Today (Barc). 2008 Jan;44(1):41-54. doi: 10.1358/dot.2008.44.1.1178469. Review.

PMID:
18301803
4.

Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.

Miyazaki T, Hanaoka K, Namiki A, Ogawa S, Kitajima T, Hosokawa T, Ishida T, Nogami S, Mashimo S.

Clin Drug Investig. 2008;28(5):313-25.

PMID:
18407717
6.

Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.

Portenoy RK, Payne R, Coluzzi P, Raschko JW, Lyss A, Busch MA, Frigerio V, Ingham J, Loseth DB, Nordbrock E, Rhiner M.

Pain. 1999 Feb;79(2-3):303-12.

PMID:
10068176
7.

Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 chinese cancer patients.

Zhu YL, Song GH, Liu DQ, Zhang X, Liu KF, Zang AH, Cheng Y, Cao GC, Liang J, Ma XZ, Ding X, Wang B, Li WL, Hu ZW, Feng G, Huang JJ, Zheng X, Jiao SC, Wu R, Ren J.

Chin J Cancer Res. 2011 Dec;23(4):317-22. doi: 10.1007/s11670-011-0317-7.

8.

From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.

Mystakidou K, Befon S, Kouskouni E, Gerolymatos K, Georgaki S, Tsilika E, Vlahos L.

Anticancer Res. 2001 May-Jun;21(3C):2225-30.

PMID:
11501851
9.

Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain.

Minami S, Kijima T, Nakatani T, Yamamoto S, Ogata Y, Hirata H, Shiroyama T, Koba T, Komuta K.

BMC Palliat Care. 2014 Oct 8;13:46. doi: 10.1186/1472-684X-13-46. eCollection 2014.

10.

A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.

Kress HG, Von der Laage D, Hoerauf KH, Nolte T, Heiskanen T, Petersen R, Lundorff L, Sabatowski R, Krenn H, Rosland JH, Saedder EA, Jensen NH.

J Pain Symptom Manage. 2008 Sep;36(3):268-79. doi: 10.1016/j.jpainsymman.2007.10.023. Epub 2008 Jun 6.

PMID:
18538974
11.

Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.

Hoya Y, Okamoto T, Yanaga K.

Support Care Cancer. 2010 Jun;18(6):761-4. doi: 10.1007/s00520-010-0869-y. Epub 2010 Mar 31.

PMID:
20354734
12.

The impact of fentanyl matrix on pain and function in spinal disorder-related chronic pain: an open label trial in Korea.

Lee JH, Yun SC, Lee JG, Choi KH, Kim DS, Chung KJ, Park YS, Eoh W.

Asian Spine J. 2011 Jun;5(2):91-9. doi: 10.4184/asj.2011.5.2.91. Epub 2011 May 2.

13.

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain.

Überall MA, Müller-Schwefe GH.

Curr Med Res Opin. 2011 Jul;27(7):1385-94. doi: 10.1185/03007995.2011.583231. Epub 2011 May 11.

PMID:
21561313
14.

A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain.

Sloan PA, Moulin DE, Hays H.

J Pain Symptom Manage. 1998 Aug;16(2):102-11.

PMID:
9737101
15.

Improved cancer pain treatment using combined fentanyl-TTS and tramadol.

Marinangeli F, Ciccozzi A, Aloisio L, Colangeli A, Paladini A, Bajocco C, Coaccioli S, Varrassi G.

Pain Pract. 2007 Dec;7(4):307-12. Epub 2007 Nov 6.

PMID:
17986161
16.

A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.

Mitra F, Chowdhury S, Shelley M, Williams G.

Pain Med. 2013 Jan;14(1):75-83. doi: 10.1111/pme.12011.

17.

Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.

Mystakidou K, Befon S, Tsilika E, Dardoufas K, Georgaki S, Vlahos L.

Oncology. 2002;62(1):9-16.

PMID:
11810038
18.

Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.

Ravera E, Di Santo S, Bosco R, Arboscello C, Chiarlone R.

Aging Clin Exp Res. 2011 Oct-Dec;23(5-6):328-32.

PMID:
22526067
19.

Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).

Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK.

Pain. 2001 Mar;91(1-2):123-30.

PMID:
11240084
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk